HIGHLIGHTS
- who: PLEURA et al. from the Division Lille University have published the Article: ISSPP CONGRESS 2022 3RD CONGRESS OF THE INTERNATIONAL SOCIETY FOR THE STUDY OF PLEURA AND PERITONEUM, in the Journal: (JOURNAL)
- what: The experiments showed that the combination of oxaliplatin+ATR inhibitor (VOX)+ anti-PD1 is highly efficient to treat PM and induces a long-term anti-tumor immunity in two different in_vivo models. The authors report the dependency of k on the tumor microenvironment (TME) using quantitative histology. The authors evaluate the impact of delayed presentation and treatment delays on oncological outcomes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.